| 2022-10-13 | +4042.6% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2022-10-12 | +3085.2% | legal | SEC EDGAR | TTOO 8-K: 2.02, 5.07, 7.01, 8.01 (SEC Filing) |
| 2026-03-19 | +2101.9% | news | Meyka | TTOO stock $0.0001 on NASDAQ 19 Mar 2026 Market Closed: top losers risk - Meyka |
| 2026-02-03 | +355.9% | news | PR Newswire | T2 Biosystems, Inc. Announces Intent to Complete Winding Down of Operations |
| 2026-02-03 | +355.9% | news | Yahoo Finance | T2 Biosystems, Inc. Announces Intent to Complete Winding Down of Operations - Yahoo Finance |
| 2025-02-18 | +268.1% | news | The Business Journals | Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers - The Business Journals |
| 2023-08-02 | +123.9% | news | StockInvest.us | T2 Biosystems, Inc. (TTOO) Stock Review: High Risk, High Reward - StockInvest.us |
| 2023-10-12 | -72.4% | legal | SEC EDGAR | TTOO 8-K: 2.02, 7.01, 8.01 (SEC Filing) |
| 2025-02-11 | -59.4% | news | Investing.com | T2 Biosystems to be delisted from Nasdaq - Investing.com |
| 2023-10-13 | -58.9% | news | The Motley Fool | Why Shares of T2 Biosystems Are Falling Friday - The Motley Fool |
| 2023-07-06 | +56.4% | legal | SEC EDGAR | TTOO 8-K: 1.01, 3.02, 5.03 (SEC Filing) |
| 2025-02-14 | +53.1% | legal | SEC EDGAR | TTOO 8-K: 2.05, 5.02and8.01 (SEC Filing) |
| 2023-07-31 | +35.9% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-07-31 | +35.9% | M&A | Yahoo Finance | GSA Capital Partners LLP Acquires Stake in T2 Biosystems Inc - Yahoo Finance |
| 2023-07-12 | -29.9% | legal | SEC EDGAR | TTOO 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-02-12 | +29.0% | legal | Seeking Alpha | T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands |
| 2023-02-13 | -24.5% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2025-04-07 | -23.9% | legal | SEC EDGAR | TTOO 8-K: 5.02 (SEC Filing) |
| 2023-06-09 | -23.5% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-06-05 | -22.7% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-09-18 | +22.4% | legal | SEC EDGAR | TTOO 8-K: 5.02 and 5.07 (SEC Filing) |
| 2023-08-24 | -22.4% | news | Yahoo Finance | Is T2 Biosystems a Hidden Gem or a Value Trap? An In-Depth Analysis - Yahoo Finance |
| 2023-08-24 | -22.4% | earnings | InvestorPlace | T2 Biosystems Preps to Resell 141 Million Shares of TTOO Stock - InvestorPlace |
| 2022-08-09 | +19.9% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-05-25 | -19.8% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2023-08-11 | +18.7% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2025-02-20 | -17.9% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2025-02-20 | -17.9% | news | Investing.com | T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com |
| 2024-03-18 | -17.7% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-09-09 | -16.8% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2022-07-06 | -16.8% | legal | SEC EDGAR | TTOO 8-K: 3.03, 5.03, 8.01 (SEC Filing) |
| 2024-05-07 | -16.1% | earnings | Seeking Alpha | T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript |
| 2024-05-07 | -16.1% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2023-06-06 | +15.4% | news | InvestorPlace | Why Is T2 Biosystems (TTOO) Stock Up 17% Today? - InvestorPlace |
| 2024-03-20 | -14.7% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-05-06 | -14.0% | expansion | Seeking Alpha | T2 Biosystems enters into distribution agreement in Qatar |
| 2024-05-06 | -14.0% | earnings | Seeking Alpha | T2 Biosystems GAAP EPS of -$2.66, revenue of $2.06M |
| 2024-05-06 | -14.0% | legal | SEC EDGAR | TTOO 8-K: 1.01, 2.02, 3.02, 8.01 (SEC Filing) |
| 2024-10-07 | -13.8% | earnings | Seeking Alpha | T2 Biosystems reports 35% rise in Q3 revenue |
| 2024-10-07 | -13.8% | legal | SEC EDGAR | TTOO 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-01-17 | -13.5% | legal | SEC EDGAR | TTOO 8-K: 1.01 (SEC Filing) |
| 2024-02-15 | -12.7% | earnings | Seeking Alpha | T2 Biosystems says it achieved full year 2023 total revenue of $7.2M |
| 2024-02-15 | -12.7% | earnings | Seeking Alpha | T2 Biosystems reports Q4 results |
| 2024-02-15 | -12.7% | M&A | Seeking Alpha | T2 Biosystems signs deal for conversion of $15M CRG term loan into equity |
| 2024-02-15 | -12.7% | legal | SEC EDGAR | TTOO 8-K: 1.01, 2.02, 3.02, 8.01 (SEC Filing) |
| 2024-02-16 | -12.6% | earnings | Seeking Alpha | T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript |
| 2024-02-16 | -12.6% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2024-09-16 | -11.3% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-01-07 | -11.2% | earnings | Seeking Alpha | T2 Biosystems reports preliminary Q4 product revenues of $2.3M |
| 2025-01-07 | -11.2% | legal | SEC EDGAR | TTOO 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-01-07 | -11.2% | news | Yahoo Finance | T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance |
| 2024-04-22 | -10.2% | news | Seeking Alpha | T2 Biosystems files to sell common stock, warrants |
| 2022-01-11 | -9.1% | legal | SEC EDGAR | TTOO 8-K: 2.02, 8.01 (SEC Filing) |
| 2023-10-16 | -9.0% | earnings | Seeking Alpha | T2 Biosystems falls 11% in wake of reverse stock split, preliminary earnings |
| 2023-10-16 | -9.0% | news | AskTraders | T2 Biosystems (TTOO) Stock Price Falls 9.02%, Extending Losses - AskTraders |
| 2022-08-17 | -8.3% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2024-11-12 | -7.5% | news | Investing.com | T2 Biosystems stock plunges to 52-week low of $0.55 - Investing.com |
| 2024-11-14 | -7.4% | earnings | Seeking Alpha | T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript |
| 2024-11-14 | -7.4% | earnings | Seeking Alpha | T2 Biosystems GAAP EPS of -$0.57, revenue of $1.99M |
| 2022-05-24 | -7.3% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2021-05-06 | -7.1% | legal | SEC EDGAR | TTOO 8-K: 1.01, 2.02, 8.01 (SEC Filing) |
| 2024-07-28 | -6.9% | earnings | Seeking Alpha | T2 Biosystems Q2 2024 Earnings Preview |
| 2024-12-16 | -6.8% | expansion | Seeking Alpha | T2 Biosystems announces extension of multi-year capital equipment supplier agreement with Vizient |
| 2023-03-16 | -6.5% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2021-10-04 | -6.4% | legal | SEC EDGAR | TTOO 8-K: 1.01 (SEC Filing) |
| 2023-08-09 | +6.1% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-09-20 | -6.1% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-01-23 | -6.0% | legal | SEC EDGAR | TTOO 8-K: 1.01, 1.02, 2.02, 8.01 (SEC Filing) |
| 2024-10-16 | -6.0% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2023-10-17 | -5.8% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2023-05-30 | -4.3% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-05-22 | -4.3% | legal | Seeking Alpha | T2 Biosystems regains compliance with Nasdaq rule on market value of listed securities |
| 2024-05-22 | -4.3% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2021-11-05 | -4.2% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2022-04-27 | -4.1% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2021-08-10 | -4.1% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2023-10-23 | +4.1% | expansion | Seeking Alpha | T2 Biosystems announces amendment, extension of CRG term loan agreement |
| 2023-10-23 | +4.1% | legal | SEC EDGAR | TTOO 8-K: 1.01 (SEC Filing) |
| 2021-07-23 | -4.1% | legal | SEC EDGAR | TTOO 8-K: 5.02, 5.03, 5.07, 8.01 (SEC Filing) |
| 2022-06-10 | -4.0% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2024-05-20 | -3.7% | legal | SEC EDGAR | TTOO 8-K: 1.01, 3.02 (SEC Filing) |
| 2022-02-17 | +3.6% | legal | SEC EDGAR | TTOO 8-K: 1.01, 2.02, 8.01 (SEC Filing) |
| 2023-08-03 | +3.6% | news | InvestorPlace | GSA Partners Is Betting Big on T2 Biosystems (TTOO) Stock - InvestorPlace |
| 2023-08-03 | +3.6% | news | TradingView | TTOO Stock Alert: Is T2 Biosystems the Next Meme Stock? - TradingView |
| 2023-11-01 | -3.5% | news | Seeking Alpha | T2 Biosystems regains compliance with Nasdaq listing requirements |
| 2023-11-01 | -3.5% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2024-07-29 | -3.5% | earnings | Seeking Alpha | T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript |
| 2024-07-29 | -3.5% | news | Seeking Alpha | T2 Biosystems announces commercial expansion through Malaysia and Indonesia distributor |
| 2024-07-29 | -3.5% | earnings | Seeking Alpha | T2 Biosystems GAAP EPS of -$0.66 beats by $0.31, revenue of $1.95M misses by $0.15M |
| 2024-07-29 | -3.5% | legal | SEC EDGAR | TTOO 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-10-11 | -3.4% | news | Seeking Alpha | T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript |
| 2022-07-11 | +3.2% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2021-06-28 | +3.1% | legal | SEC EDGAR | TTOO 8-K: 5.02, 5.07, 7.01 (SEC Filing) |
| 2021-05-11 | +3.0% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2024-04-11 | +2.9% | news | Seeking Alpha | T2 Biosystems shareholders vote to convert $15M CRG debt into equity |
| 2024-12-09 | +2.8% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-05-03 | -2.8% | earnings | Seeking Alpha | T2 Biosystems Q1 Earnings Preview |
| 2022-05-11 | -2.2% | legal | SEC EDGAR | TTOO 8-K: 2.02, 3.01 (SEC Filing) |
| 2024-03-28 | -2.1% | expansion | Seeking Alpha | T2 Biosystems extends contract with Vizient |
| 2024-03-28 | -2.1% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-03-12 | +2.0% | news | Seeking Alpha | T2 Biosystems receives extension to comply with Nasdaq listing requirement |
| 2024-03-12 | +2.0% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2023-02-16 | -1.9% | legal | SEC EDGAR | TTOO 8-K: 8.01 and (SEC Filing) |
| 2022-11-07 | +1.9% | legal | SEC EDGAR | TTOO 8-K: 5.02, 7.01, 8.01 (SEC Filing) |
| 2021-09-08 | -1.9% | legal | SEC EDGAR | TTOO 8-K: 1.01 (SEC Filing) |
| 2024-01-05 | +1.8% | legal | SEC EDGAR | TTOO 8-K: 5.02 (SEC Filing) |
| 2024-04-18 | +1.8% | legal | SEC EDGAR | TTOO 8-K: 1.01, 3.02, 5.03 (SEC Filing) |
| 2024-07-19 | -1.7% | legal | Seeking Alpha | T2 Biosystems files for $150M mixed securities shelf |
| 2024-07-19 | -1.7% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2022-08-30 | +1.7% | legal | SEC EDGAR | TTOO 8-K: 8.01 (SEC Filing) |
| 2022-09-30 | +1.5% | legal | SEC EDGAR | TTOO 8-K: 1.01 (SEC Filing) |
| 2022-11-10 | +1.4% | legal | SEC EDGAR | TTOO 8-K: 2.02 and (SEC Filing) |
| 2021-10-19 | +1.2% | legal | SEC EDGAR | TTOO 8-K: 5.02 (SEC Filing) |
| 2022-04-01 | +1.2% | legal | SEC EDGAR | TTOO 8-K: 1.01 (SEC Filing) |
| 2024-12-18 | +1.2% | news | Seeking Alpha | T2 Biosystems sells four T2Dx Instruments to European distributor |
| 2024-11-15 | -1.0% | legal | SEC EDGAR | TTOO 8-K: 2.02, 8.01 (SEC Filing) |
| 2023-10-25 | +1.0% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-07-20 | -0.8% | legal | SEC EDGAR | TTOO 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-02-14 | +0.8% | earnings | Seeking Alpha | T2 Biosystems Q4 2023 Earnings Preview |
| 2025-01-03 | +0.7% | legal | SEC EDGAR | TTOO 8-K: 5.02 and 5.07 (SEC Filing) |
| 2026-01-25 | -0.5% | news | TradingView | TTOO Stock Price and Chart — OTC:TTOO - TradingView |
| 2023-10-02 | +0.1% | legal | GlobeNewswire | SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation - GlobeNewswire |